Delivery Order SPE2DB20D3505-SPE2DB25FV1Q7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg tablets (100-count) valued at $1,000.16, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.12 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets in quantities of 100 on July 28, 2025, with completion expected by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,144.26 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 29, 2025. The delivery order was issued on July 28, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for dextroamphetamine-amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,597.36. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is set to complete by July 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 5 mg tablets (100-count units) valued at $1,624.47, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- This is a $1,173.66 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dextroamphetamine-Amphetamine 10 mg tablets. It has an ultimate completion date of June 30, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of dextroamphetamine-amphetamine 15 mg tablets in quantities of 100 units, with a contract value of $2,381.06 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a standard pharmaceutical procurement through the federal medical supply chain with no set-aside designation. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for dextroamphetamine-amphetamine 20 mg tablets in quantities of 100 units, with a ceiling value of $1,041.80. This is a firm fixed price delivery order with an ultimate completion date of August 18, 2025. The award was non-set-aside and competitively awarded, reflecting AmerisourceBergen's capability to meet federal procurement requirements. This delivery order is issued under the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 units of 15 mg d-amphetamine tablets, with a contract value of $1,077.65. The award, issued on July 28, 2025, with an ultimate completion date of the same date, reflects a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 10 mg dextroamphetamine-amphetamine tablets. The contract has a potential value of $1,487.04 and a completion date of February 26, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will be providing these pharmaceutical products from its Corporate Office location in Conshohocken,...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FV1Q7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets (100-count packages) valued at $1,859.55 with an ultimate completion date of August 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The company's contract portfolio with the Defense Logistics Agency demonstrates extensive experience delivering a comprehensive range of pharmaceutical products, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for controlled-substance pharmaceuticals aligns with AmerisourceBergen's established role as a preferred supplier within the DLA's medical supply chain and reflects the company's capability to fulfill federal healthcare procurement requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/11/25 |